Fibrinogen-mediated platelet aggregation depends on disulfide exchange.

Effect of the disulfide-exchange blocker bacitracin on agonist-induced platelet aggregation. Bacitracin was added to PRP, and aggregation induced by the agonists indicated was assessed without further incubation. Shown is one representative experiment of 5.